Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsHow Precisely Can Prostate Cancer Be Managed?Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical ProstatectomyDecipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy.Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.Prostate cancer radiomics and the promise of radiogenomics.Tissue-based biomarkers in prostate cancer.The Use of Biomarkers in Prostate Cancer Screening and Treatment.[Molecular biomarkers and prognostic factors for prostate cancer].
P2860
Q26750672-3ECF4208-F0DA-4F2D-85A0-1C55FE08B194Q28078942-E1D426A5-B76A-4983-BB86-CE60970FD53DQ30276626-CA3ABA1C-8896-46A4-BC95-D2ECDB1DDEB1Q35868145-E62BD517-9B5D-4798-8224-F80E1EF93CC4Q37463713-35602D54-73C7-4DB2-BCD9-3E7FCFDDA853Q38356863-D4D5606F-B63B-424F-97E3-9B42AD68B6B7Q38767990-CFBC59A5-D949-4ED4-B0EA-5ACF330A073DQ38841717-A7AEF384-4D6F-4943-8DEB-20E9A9413AD1Q41520709-D8F20F34-4E83-45C3-A5C7-6C9260CC89B8Q41540713-2B0CBAD9-50F3-4457-9F17-BFDFD85E81FAQ47135421-AF384E97-785D-40ED-B826-5234246AAE88Q47144748-17D56F64-AA86-4406-928C-7D6CAAD3328FQ52689045-D705E2AA-E130-4897-A0FF-1BD9D3A2BEC3Q53251387-BDB7A8EE-4E11-4CD0-9848-CAD360EF5BBE
P2860
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of a genomic classifier ...... prostate cancer after surgery
@ast
Effect of a genomic classifier ...... prostate cancer after surgery
@en
type
label
Effect of a genomic classifier ...... prostate cancer after surgery
@ast
Effect of a genomic classifier ...... prostate cancer after surgery
@en
prefLabel
Effect of a genomic classifier ...... prostate cancer after surgery
@ast
Effect of a genomic classifier ...... prostate cancer after surgery
@en
P2093
P2860
P356
P1433
P1476
Effect of a genomic classifier ...... prostate cancer after surgery
@en
P2093
Amar Singh
Christine Buerki
Daniel Holmes
Darby J Thompson
David Albala
Gordon Brown
John Hornberger
Ketan K Badani
Naveen Kella
P2860
P304
P356
10.1111/BJU.12789
P577
2014-08-11T00:00:00Z